A role for PVRL4-driven cell-cell interactions in tumorigenesis.

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Cancer cells adapt to changing extracellular matrix environments during tumor progression.
• Loss of matrix attachment normally imposes growth constraints on cancer cells.
• Identifying genes that promote anchorage-independent growth is crucial for understanding tumor progression.

Purpose of the Study:

• To identify genes enabling cancer cell proliferation independent of matrix anchorage.
• To investigate the role of the cell adhesion molecule PVRL4 (Nectin-4) in promoting anchorage-independence.
• To explore PVRL4 as a potential therapeutic target in cancer.

Main Methods:

• A gain-of-function screen was employed to identify genes facilitating matrix-independent proliferation.
• Investigated the mechanism by which PVRL4 promotes anchorage-independence, focusing on cell-to-cell attachment and signaling pathways.
• Assessed the dependency of breast cancer cell transformation on PVRL4.
• Utilized orthotopic tumor implantation models in vivo to evaluate therapeutic strategies.

Main Results:

• A gain-of-function screen identified PVRL4 (Nectin-4) as a key mediator of anchorage-independent growth.
• PVRL4 promotes anchorage-independence by enhancing cell-to-cell adhesion and activating the integrin β4/SHP-2/c-Src pathway.
• Breast cancer cell transformation is dependent on PVRL4.
• Copy number gains and focal amplifications of the PVRL4 locus are frequent in solid tumors.
• Monoclonal antibodies blocking PVRL4-mediated cell-to-cell attachment inhibited tumor growth in vivo.

Conclusions:

• PVRL4 (Nectin-4) is a critical driver of anchorage-independent cancer cell growth and transformation.
• PVRL4-mediated cell-to-cell attachment represents a novel therapeutic vulnerability in solid tumors.
• Targeting PVRL4 with monoclonal antibodies is a promising strategy for cancer therapy.